share_log

Returns At Select Medical Holdings (NYSE:SEM) Appear To Be Weighed Down

Returns At Select Medical Holdings (NYSE:SEM) Appear To Be Weighed Down

精選醫療控股公司(紐約證券交易所代碼:SEM)的回報似乎受到壓制
Simply Wall St ·  2023/11/07 06:06

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? In a perfect world, we'd like to see a company investing more capital into its business and ideally the returns earned from that capital are also increasing. This shows us that it's a compounding machine, able to continually reinvest its earnings back into the business and generate higher returns. In light of that, when we looked at Select Medical Holdings (NYSE:SEM) and its ROCE trend, we weren't exactly thrilled.

你知道有一些財務指標可以爲潛在的多袋人提供線索嗎?在一個完美的世界中,我們希望看到一家公司向其業務投入更多資本,理想情況下,從這些資本中獲得的回報也在增加。這向我們表明,它是一臺複合機器,能夠持續將其收益再投資到業務中併產生更高的回報。有鑑於此,當我們研究精選醫療控股公司(紐約證券交易所代碼:SEM)及其投資回報率趨勢時,我們並不十分興奮。

Return On Capital Employed (ROCE): What Is It?

資本使用回報率(ROCE):這是什麼?

For those who don't know, ROCE is a measure of a company's yearly pre-tax profit (its return), relative to the capital employed in the business. The formula for this calculation on Select Medical Holdings is:

對於那些不知道的人來說,ROCE是衡量公司年度稅前利潤(其回報率)的指標,相對於該業務使用的資本。精選醫療控股公司的計算公式爲:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

已動用資本回報率 = 息稅前收益(EBIT)÷(總資產-流動負債)

0.08 = US$522m ÷ (US$7.7b - US$1.2b) (Based on the trailing twelve months to September 2023).

0.08 = 5.22 億美元 ¥(77 億美元-12 億美元) (基於截至2023年9月的過去十二個月)

Thus, Select Medical Holdings has an ROCE of 8.0%. On its own, that's a low figure but it's around the 9.8% average generated by the Healthcare industry.

因此,精選醫療控股公司的投資回報率爲8.0%。就其本身而言,這是一個很低的數字,但約爲醫療保健行業的9.8%的平均水平。

See our latest analysis for Select Medical Holdings

查看我們對精選醫療控股的最新分析

roce
NYSE:SEM Return on Capital Employed November 7th 2023
紐約證券交易所:SEM 已用資本回報率 2023 年 11 月 7 日

Above you can see how the current ROCE for Select Medical Holdings compares to its prior returns on capital, but there's only so much you can tell from the past. If you'd like, you can check out the forecasts from the analysts covering Select Medical Holdings here for free.

在上方你可以看到Select Medical Holdings當前的投資回報率與之前的資本回報率相比如何,但從過去可以看出來只有這麼多。如果你願意,你可以在這裏免費查看報道Select Medical Holdings的分析師的預測。

The Trend Of ROCE

ROCE 的趨勢

In terms of Select Medical Holdings' historical ROCE trend, it doesn't exactly demand attention. The company has consistently earned 8.0% for the last five years, and the capital employed within the business has risen 23% in that time. Given the company has increased the amount of capital employed, it appears the investments that have been made simply don't provide a high return on capital.

就精選醫療控股公司的歷史投資回報率趨勢而言,這並不完全值得關注。在過去五年中,該公司的收入一直保持在8.0%,在此期間,公司內部使用的資本增長了23%。鑑於該公司增加了動用資本金額,看來已經進行的投資根本無法提供很高的資本回報率。

The Bottom Line On Select Medical Holdings' ROCE

精選醫療控股公司投資回報率的底線

Long story short, while Select Medical Holdings has been reinvesting its capital, the returns that it's generating haven't increased. Unsurprisingly, the stock has only gained 17% over the last five years, which potentially indicates that investors are accounting for this going forward. As a result, if you're hunting for a multi-bagger, we think you'd have more luck elsewhere.

長話短說,儘管Select Medical Holdings一直在對其資本進行再投資,但其產生的回報並未增加。毫不奇怪,該股在過去五年中僅上漲了17%,這可能表明未來投資者正在考慮這一點。因此,如果你正在尋找一款多功能裝袋,我們認爲你在其他地方運氣會更好。

Select Medical Holdings does have some risks, we noticed 2 warning signs (and 1 which is concerning) we think you should know about.

Select Medical Holdings確實存在一些風險,我們注意到兩個警告信號(還有一個令人擔憂),我們認爲你應該知道。

While Select Medical Holdings may not currently earn the highest returns, we've compiled a list of companies that currently earn more than 25% return on equity. Check out this free list here.

儘管Select Medical Holdings目前可能無法獲得最高的回報,但我們編制了一份目前股本回報率超過25%的公司名單。在這裏查看這份免費清單。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St 的這篇文章本質上是籠統的。我們僅使用公正的方法提供基於歷史數據和分析師預測的評論,我們的文章並非旨在提供財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不會考慮最新的價格敏感型公司公告或定性材料。華爾街只是沒有持有上述任何股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論